TALPHERA, INC. Depreciation
TALPHERA, INC. (TLPH) reported Depreciation of $800.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-03-31
- TALPHERA, INC. depreciation for the quarter ending 2022-12-31 was $100.00K, a 66.67% decline year-over-year.
- TALPHERA, INC. depreciation for the quarter ending 2022-09-30 was $200.00K, a 33.33% decline year-over-year.
- TALPHERA, INC. depreciation for the quarter ending 2022-06-30 was $200.00K, a 33.33% decline year-over-year.
- TALPHERA, INC. depreciation for the quarter ending 2022-03-31 was $300.00K.
- TALPHERA, INC. depreciation for fiscal 2022 was $800.00K, a 27.27% decline from fiscal 2021.
- TALPHERA, INC. depreciation for fiscal 2021 was $1.10M, a 0.00% change from fiscal 2020.
- TALPHERA, INC. depreciation for fiscal 2020 was $1.10M, a 22.22% increase from fiscal 2019.
- TALPHERA, INC. depreciation for fiscal 2019 was $900.00K, a 80.00% increase from fiscal 2018.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $300.00K derived: sum of 2 quarters · filed 2023-03-31 | $500.00K derived: sum of 3 quarters · filed 2023-03-31 | $800.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-14 | $400.00K derived: sum of 2 quarters · filed 2022-11-14 | $700.00K 10-Q · filed 2022-11-14 | $1.00M derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-11 | $500.00K 10-Q · filed 2022-08-11 | $800.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.10M derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $300.00K derived: 10-K 12 month − 3 quarters · filed 2023-03-31 | $600.00K derived: sum of 2 quarters · filed 2023-03-31 | $900.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.20M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $600.00K derived: sum of 2 quarters · filed 2023-03-31 | $900.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.10M 10-K · filed 2023-03-31 |
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-14 | $600.00K derived: sum of 2 quarters · filed 2022-11-14 | $800.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-11 | $500.00K 10-Q · filed 2022-08-11 | ||
| 2020-12-31 | $1.10M 10-K · filed 2022-03-10 | |||
| 2019-12-31 | $900.00K 10-K · filed 2021-03-15 | |||
| 2018-12-31 | $500.00K 10-K · filed 2021-03-15 | |||
| 2017-12-31 | $1.70M 10-K · filed 2020-03-16 | |||
| 2016-12-31 | $2.10M 10-K · filed 2019-03-07 | |||
| 2015-12-31 | $2.00M 10-K · filed 2018-03-09 | |||
| 2014-12-31 | $900.00K 10-K · filed 2017-03-03 | |||
| 2013-12-31 | $600.00K 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |